Old drugs--new uses.
作者信息
Aronson J K
出版信息
Br J Clin Pharmacol. 2007 Nov;64(5):563-5. doi: 10.1111/j.1365-2125.2007.03058.x.
Abstract
摘要
相似文献
1
Old drugs--new uses.
Br J Clin Pharmacol. 2007 Nov;64(5):563-5. doi: 10.1111/j.1365-2125.2007.03058.x.
2
[Clinical development of new drugs and pharmacology].
Nihon Yakurigaku Zasshi. 2011 Nov;138(5):201-4. doi: 10.1254/fpj.138.201.
3
2007 FDA drug approvals: a year of flux.
Nat Rev Drug Discov. 2008 Feb;7(2):107-9. doi: 10.1038/nrd2514.
4
New directions for drug discovery.
Dialogues Clin Neurosci. 2006;8(3):295-301. doi: 10.31887/DCNS.2006.8.3/mspedding.
5
Guiding drug discovery through 2003.
Nat Rev Drug Discov. 2003 Jan;2(1):3. doi: 10.1038/nrd1003.
6
[New active agents approved as pharmaceutical specialties in 2002].
J Pharm Belg. 2003;58(1):1-20.
7
Natural products in drug discovery and development.
J Nat Prod. 1997 Jan;60(1):52-60. doi: 10.1021/np9604893.
8
Are we losing good drugs?
Clin Pediatr (Phila). 2001 Jun;40(6):325-6. doi: 10.1177/000992280104000603.
9
What does it take to produce a breakthrough drug?
Nat Rev Drug Discov. 2015 Mar;14(3):161-2. doi: 10.1038/nrd4570.
10
Avoiding premature licensing.
Nat Rev Drug Discov. 2006 Dec;5(12):985-6. doi: 10.1038/nrd2203.
引用本文的文献
1
Improving computational drug repositioning through multi-source disease similarity networks.
Sci Rep. 2025 Aug 21;15(1):30773. doi: 10.1038/s41598-025-04772-0.
2
Editorial: Old drugs: confronting recent advancements and challenges.
Front Pharmacol. 2025 Mar 19;16:1565890. doi: 10.3389/fphar.2025.1565890. eCollection 2025.
3
A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs.
Int J Mol Sci. 2024 Sep 23;25(18):10230. doi: 10.3390/ijms251810230.
4
Drug Repurposing in the Chemotherapy of Infectious Diseases.
Molecules. 2024 Jan 29;29(3):635. doi: 10.3390/molecules29030635.
5
AMMVF-DTI: A Novel Model Predicting Drug-Target Interactions Based on Attention Mechanism and Multi-View Fusion.
Int J Mol Sci. 2023 Sep 15;24(18):14142. doi: 10.3390/ijms241814142.
6
Stereoselective Solvolysis in the Synthesis of Dorzolamide Intermediates.
ACS Omega. 2023 Jul 21;8(31):28851-28858. doi: 10.1021/acsomega.3c03959. eCollection 2023 Aug 8.
7
Screening of Potential Inhibitors Targeting the Main Protease Structure of SARS-CoV-2 via Molecular Docking, and Approach with Molecular Dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA.
Mol Biotechnol. 2024 Aug;66(8):1919-1933. doi: 10.1007/s12033-023-00831-x. Epub 2023 Jul 25.
8
Knowledge Mapping of Drug Repositioning's Theme and Development.
Drug Des Devel Ther. 2023 Apr 18;17:1157-1174. doi: 10.2147/DDDT.S405906. eCollection 2023.
9
The Antidepressant Duloxetine Inhibits Platelet Function and Protects against Thrombosis.
Int J Mol Sci. 2022 Feb 26;23(5):2587. doi: 10.3390/ijms23052587.
10
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
Sci Rep. 2021 Jun 10;11(1):12310. doi: 10.1038/s41598-021-91625-1.
本文引用的文献
1
Management strategies for patients with pulmonary hypertension in the intensive care unit.
Crit Care Med. 2007 Sep;35(9):2037-50. doi: 10.1097/01.ccm.0000280433.74246.9e.
2
Thioridazine: resurrection as an antimicrobial agent?
Br J Clin Pharmacol. 2007 Nov;64(5):566-74. doi: 10.1111/j.1365-2125.2007.03021.x. Epub 2007 Aug 31.
3
Diagnosis and treatment of acute promyelocytic leukemia.
Curr Oncol Rep. 2007 Sep;9(5):337-44. doi: 10.1007/s11912-007-0045-9.
4
Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide mediated pathway independent of glutathione S-transferase P1-1 inhibition.
Cancer Res. 2007 Aug 15;67(16):7856-64. doi: 10.1158/0008-5472.CAN-07-0151.
5
New uses for old drugs.
Nature. 2007 Aug 9;448(7154):645-6. doi: 10.1038/448645a.
6
Detrusor overactivity successfully treated with duloxetine.
J Obstet Gynaecol. 2007 May;27(4):438-40. doi: 10.1080/01443610701359621.
7
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
N Engl J Med. 2007 May 24;356(21):2131-42. doi: 10.1056/NEJMoa067208.
8
Maintenance therapy for multiple myeloma with particular emphasis on thalidomide.
Onkologie. 2006 Dec;29(12):582-90. doi: 10.1159/000096262. Epub 2006 Dec 11.
9
The contributions of Paul Ehrlich to infectious disease.
J Infect. 2007 Mar;54(3):221-4. doi: 10.1016/j.jinf.2004.05.022. Epub 2006 Mar 29.
10
A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
Am J Trop Med Hyg. 2005 May;72(5):518-26.
Zotero 插件